Cancer Epidemiology The goal of the Cancer Epidemiology Program is to discover new knowledge relevant to cancer etiology, diagnosis, prognosis, survival, and prevention using an interdisciplinary epidemiologic approach. This research has been conducted primarily in the context of large population-based case-control studies in North Carolina with an emphasis on inclusion of African-Americans. The studies have typically included collection of diverse exposure data, genomic DNA, and tumor samples. Cancers of particular interest in North Carolina and other studies have included breast cancer, colorectal cancer, malignant melanoma, prostate cancer, head and neck cancer, and childhood cancer. An expanding area of emphasis is the influence of genetic and environmental factors on cancer survivorship. Case groups from selected large population-based case control studies form the basis of survivor cohorts that are being updated and evaluated for multiple predictors of survival. Highlights of Program research include the identification of breast cancer molecular subtypes and their relationship with risk factors and prognosis among African-American women. This important finding will be further investigated by the ongoing enrollment of 2000 newly-diagnosed breast cancer patients who will be followed rigorously for five years to determine interactions between treatment and breast cancer molecular subtypes, as well as to evaluate racial disparities in breast cancer survival and access to care. Other Program highlights include new findings on the role of obesity and physical activity in breast cancer risk and survival, unique expression patterns in breast cancer and breast tissues, and the association between exposures and BRAF-mutant melanoma. The Program adds value to the Center through its population-based study resources that provide the basis for unique interdisciplinary studies. Its leader, Dr. Andrew Olshan, is a senior cancer epidemiologist with an extensive research and training program. In 2009, the Program had 16 members with total cost funding of $9.7 million, including $5.9 million in NCI funding. Publications averaged ~100 per years over the last six years;12% were intraprogrammatic and 28% were interprogrammatic. Future plans for the Program include an emphasis on studies of diverse exposures and gene-environment interaction in relation to the risk of several cancers as well as cancer survivorship. The availability of DNA from over 12,000 cases and a similar number of controls from population-based studies has contributed to two large-scale genome-wide association studies (CBCS and CHANCE). Translational studies using population-based samples will also incorporate tumor profile results from microarray studies. For example, studies to further elucidate the relationship between cancer risk factors and gene expression in precancerous and normal tissue are under way.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-38
Application #
8594142
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
38
Fiscal Year
2014
Total Cost
$151,662
Indirect Cost
$66,181
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Williams, Lindsay A; Nichols, Hazel B; Hoadley, Katherine A et al. (2018) Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study. Cancer Causes Control 29:25-32
Amunugama, Ravindra; Willcox, Smaranda; Wu, R Alex et al. (2018) Replication Fork Reversal during DNA Interstrand Crosslink Repair Requires CMG Unloading. Cell Rep 23:3419-3428
Little, Michael S; Pellock, Samuel J; Walton, William G et al. (2018) Structural basis for the regulation of ?-glucuronidase expression by human gut Enterobacteriaceae. Proc Natl Acad Sci U S A 115:E152-E161
Knott, Simon R V; Wagenblast, Elvin; Khan, Showkhin et al. (2018) Erratum: Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 556:135
Anderson, Chelsea; Smitherman, Andrew B; Nichols, Hazel B (2018) Conditional relative survival among long-term survivors of adolescent and young adult cancers. Cancer 124:3037-3043
Liu, Meng-Xi; Jin, Lei; Sun, Si-Jia et al. (2018) Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene 37:1637-1653
Curtis 2nd, Alan D; Jensen, Kara; Van Rompay, Koen K A et al. (2018) A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques. J Med Primatol 47:288-297
Butler, Kyle V; Chiarella, Anna M; Jin, Jian et al. (2018) Targeted Gene Repression Using Novel Bifunctional Molecules to Harness Endogenous Histone Deacetylation Activity. ACS Synth Biol 7:38-45
Zhang, Yang; Hwang, Bin-Jin; Liu, Zhen et al. (2018) BP180 dysfunction triggers spontaneous skin inflammation in mice. Proc Natl Acad Sci U S A 115:6434-6439
Evangelista, Flor; Roth, Aleeza J; Prisayanh, Phillip et al. (2018) Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope. J Autoimmun 89:171-185

Showing the most recent 10 out of 1525 publications